{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:21:39Z","timestamp":1777922499513,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Graves' disease is the most common cause of thyrotoxicosis and is characterized by ophthalmopathy with proptosis, chemosis, or conjunctival injection; pretibial myxedema; and thyroid acropachy. It is an autoimmune disease that can be genetic or influenced by coexisting environmental factors such as exposure to anticancer drugs, including immune checkpoint inhibitors. The incidence rate of breast cancer is increasing due to rising awareness of risk factors and screening for breast cancer, and the mortality rate is decreasing due to recent advances in cancer treatment. However, there are side effects that are attributed to these treatment modalities, manifesting in various forms in breast cancer survivors, which are reflected in the patient in this case study.<\/jats:p>","DOI":"10.1089\/mab.2023.0011","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T09:18:32Z","timestamp":1703841512000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-2401","authenticated-orcid":false,"given":"Chinmeri U.","family":"Achonu","sequence":"first","affiliation":[{"name":"Faculty of Clinical Sciences, Lagos University Teaching Hospital, Lagos, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwarotimi B.","family":"Olopade","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology, College of Medicine, University of Lagos, Lagos, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir O.","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Medicine, Federal Teaching Hospital Katsina, Katsina, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abimbola A.","family":"Fadeyi","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Lagos University Teaching Hospital, Lagos, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufemi A.","family":"Fasanmade","sequence":"additional","affiliation":[{"name":"Department of Medicine, Endocrinology, College of Medicine, University of Lagos, Lagos, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.10.011"},{"key":"e_1_3_7_3_2","unstructured":"Davies TF. Pathogenesis of Graves' Disease. Uptodate-Wolter Kluwer Health. (Ross DS Mulder JE. eds.) 2018. Available from: https:\/\/www.uptodate.com\/contents\/pathogenesis-of-graves-disease [Last accessed: May1 2022]."},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0426-8"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00344"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.05.013"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345548"},{"key":"e_1_3_7_8_2","unstructured":"Schraga ED. Hyperthyroidism Thyroid Storm and Graves Disease. Medscape; 2022. Available from: https:\/\/emedicine.medscape.com\/article\/767130-overview [Last accessed: August7 2022]."},{"key":"e_1_3_7_9_2","unstructured":"Lee SL Ananthakrishnan S. Hyperthyroidism and Thyrotoxicosis. (Khadori L. ed.) WebMDLLC. Medscape; 2022. Available from: https:\/\/emedicine.medscape.com\/article\/121865-overview [Last accessed: August7 2022]."},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229"},{"key":"e_1_3_7_11_2","doi-asserted-by":"crossref","unstructured":"Vanderpump MPJ. Epidemiology of Thyroid Disease and Swelling. Oxford Textbook of Endocrinology and Diabetes 3e. Oxford University Press: Oxford; 2021; pp. 375\u2013383; doi: 10.1093\/med\/9780198870197.003.0045","DOI":"10.1093\/med\/9780198870197.003.0045"},{"key":"e_1_3_7_12_2","first-page":"37","article-title":"Benign thyroid disease in pregnancy: A state of the art review","volume":"6","author":"Tingi E","year":"2016","unstructured":"Tingi E, , Syed AA, , Kyriacou A, et al. Benign thyroid disease in pregnancy: A state of the art review. J Clin Transl Endocrinol, 2016; 6:37\u201349; doi: 10.1016\/j.jcte.2016.11.001.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-022-00145-5"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8285-8"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3588"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-1485-9_3"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102845"},{"key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/509764","article-title":"Autoimmune thyroid disorders","volume":"2013","author":"Iddah MA","year":"2013","unstructured":"Iddah MA, , Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol, 2013; 2013:1\u20139; doi: 10.1155\/2013\/509764","journal-title":"ISRN Endocrinol"},{"key":"e_1_3_7_19_2","unstructured":"Amit Akirov M. Hyperthyroidism and Thyrotoxicosis: Diagnosis and Management. 2023. Available from: https:\/\/www.endocrinologyadvisor.com\/home\/topics\/thyroid\/hyperthyroidism-and-thyrotoxicosis-diagnosis-and-management [Last accessed: July9 2022]."},{"key":"e_1_3_7_20_2","unstructured":"Fasanmade O. The Scope of Cardiac Complications of Thyrotoxicosis in Lagos Nigeria. 2021. Available from: https:\/\/www.academia.edu\/es\/65129240\/The_scope_of_cardiac_complications_of_thyrotoxicosis_in_Lagos_Nigeria [Last accessed: August7 2022]."},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.83331"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020156"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.23937\/2378-3419\/3\/2\/1052"},{"issue":"2","key":"e_1_3_7_24_2","first-page":"124","article-title":"Thyropathies in women with breast cancer","volume":"25","author":"Hajtmanov\u00e1 E","year":"2012","unstructured":"Hajtmanov\u00e1 E, , Mur\u00ed\u0148 P, , Kinclov\u00e1 I, et al. Thyropathies in women with breast cancer. Clin Oncol, 2012; 25(2):124\u2013129; Slovak. PMID: 22533887.","journal-title":"Clin Oncol"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000273"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.36348\/sijb.2019.v02i11.001"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05675-6"},{"issue":"6","key":"e_1_3_7_28_2","first-page":"1603","article-title":"Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival","volume":"18","author":"Jiskra J","year":"2007","unstructured":"Jiskra J, , Barkmanova J, , Limanova Z, et al. Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival. Oncol Rep, 2007; 18(6):1603\u20131611; doi: 10.3892\/or.18.6.1603","journal-title":"Oncol Rep"},{"issue":"1","key":"e_1_3_7_29_2","first-page":"125","article-title":"Hasimoto s thyroiditis and breast cancer: Coincidence or correlation?","volume":"51","author":"Valea A","year":"2016","unstructured":"Valea A, , Ghervan CR, , Morar AN, et al. Hasimoto s thyroiditis and breast cancer: Coincidence or correlation?. Arch Balkan Med Union, 2016; 51(1):125\u2013128; Available from https:\/\/www.researchgate.net\/publication\/316136009_Hasimoto's_thyroiditis_and_breast_cancer_Coincidence_or_correlation","journal-title":"Arch Balkan Med Union"},{"key":"e_1_3_7_30_2","unstructured":"Marina D Rasmussen \u00c5K Buch-Larsen K et al. Influence of the Anti-Oestrogens Tamoxifen and Letrozole on Thyroid Function in Women with Early and Advanced Breast Cancer: A Systematic Review. U.S. National Library of Medicine; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9883413 [Last accessed: August7 2022]."},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.18410\/jebmh\/2019\/222"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0431"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4297-2"},{"key":"e_1_3_7_34_2","unstructured":"Yeung S-CJ. Graves Disease. (Kahdori R. ed.) Medscape; 2023. Available from: https:\/\/emedicine.medscape.com\/article\/120619-overview [Last accessed: February9 2023]."},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2021.194"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2470"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28493"},{"issue":"6","key":"e_1_3_7_38_2","first-page":"46","article-title":"Relationship of breast cancer association with thyroid disorders in IRAQI women patients","volume":"21","author":"Qasim MK","year":"2020","unstructured":"Qasim MK, , Tektook NK. Relationship of breast cancer association with thyroid disorders in IRAQI women patients. J Nat Remedies, 2020; 21(6):46\u201352; Available from: https:\/\/www.researchgate.net\/profile\/Nihad-Tektook-2\/publication\/345035391_RELATIONSHIP_OF_BREAST_CANCER_ASSOCIATION_WITH_THYROID_DISORDERS_IN_IRAQI_WOMEN_PATIENTS\/links\/5fa82c01a6fdcc","journal-title":"J Nat Remedies"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034125"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm.2011.819"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000460246"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.5114\/pjr.2019.84096"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780190050726.003.0046"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2014.05.025"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.167613"},{"key":"e_1_3_7_47_2","doi-asserted-by":"crossref","unstructured":"De Groot S Janssen LGM Charehbili A et al. Thyroid Function Alters During Neoadjuvant Chemotherapy in Breast Cancer Patients: Results from the NEOZOTAC Trial (Boog 2010\u201301). U.S. National Library of Medicine-Breast Cancer Research and Treatment; 2015; Vol. 149; pp. 461\u2013466; Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4308642 [Last accessed: August 14 2022].","DOI":"10.1007\/s10549-014-3256-4"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP14445.OR"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00813"},{"issue":"2","key":"e_1_3_7_50_2","first-page":"e34696","article-title":"A rare case of pembrolizumab-associated graves' disease","volume":"15","author":"Alqaisi S","year":"2023","unstructured":"Alqaisi S, , Rahman A. A rare case of pembrolizumab-associated graves' disease. Cureus, 2023; 15(2):e34696; doi: 10.7759\/cureus.34696","journal-title":"Cureus"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.64205"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3003"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.031"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32832cf824"},{"key":"e_1_3_7_55_2","unstructured":"Grani G ; Dicorato P ; Dainelli M; et al. Thyroid Diseases in Women with Breast Cancer. U.S. National Library of Medicine. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23306753 [Last accessed: August15 2022]"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_66_19"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mab.2023.0011","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mab.2023.0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:22:16Z","timestamp":1777666936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mab.2023.0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1089\/mab.2023.0011"],"URL":"https:\/\/doi.org\/10.1089\/mab.2023.0011","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}